Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Adi Jaffe

Adi Jaffe

Alternatives Behavioral Health LLC., USA

Title: Mobile breathalyzers in substance use disorder treatment: Utilization, validity, and utility in treatment provision

Biography

Biography: Adi Jaffe

Abstract

Aims: To describe the feasibility, implementation, validity and utilization of mobile momentary-assessment breathalyzers within the context of an intensive outpatient (IOP) treatment for Alcohol Use Disorder (AUD). Methods: Fifty-five participants in an IOP treatment program in Southern California were provided breathalyzers at the onset of treatment. Breathalyzer assessment schedules were set based on client’s self-report of sleep schedule and three to five assessments (M=4) per day were conducted remotely. Breathalyzer data was recorded for the duration of treatment, which lasted between two-to-six months (M=3.5 months).Participants were given a short survey to assess their satisfaction with the Breathalyzer system. Data preparation and analysis was conducted using SPSS. Results: Analysisindicated substantial presence of missing data when looking at individual data points. Analysis of relative missing frequency, relative non-zero BAC readings as well as maximum BAC were conducted for the overall sample and based on initial treatment-goal selection. Conclusions: Our study reveals that the utilization of momentary substance detection methods, such as a Breathalyzer, within an IOP treatment context is feasible. Furthermore, the study reveals specific analysis recommendations for providers engaged in such data collection. Finally the use of reporting adherence as a measure of treatment progress is suggested given the relationship between treatment success and Breathalyzer reporting observance.